Clinical trial
Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant…
NCT00145041 · Acrotech Biopharma Inc., Industry · Completed
Key facts
| NCT number | NCT00145041 |
|---|---|
| Title | Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction |
| Official title | An Evaluation of the Pharmacokinetic Profile of VSLI (Vincristine Sulfate Liposome Injection, 0.16 mg/mL) in Patients With Malignant Melanoma and Hepatic Dysfunction Secondary to Metastases |
| Lead sponsor | Acrotech Biopharma Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malignant Melanoma |
| Intervention type | Drug |
| Interventions | Vincristine Sulfate Liposomes Injection |
| Enrollment | 7 |
| Start date | Feb 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 5, 2005 |
| Last update posted | Dec 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: